Evaluation and Treatment of Eye Complications of Vaccinia Vaccination

PHASE2CompletedINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

April 19, 2004

Study Completion Date

August 15, 2007

Conditions

Vaccinia

Interventions

DRUG

NP-016 Vaccine Immune Globulin (IV-VIG)

Trial Locations (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Eye Institute (NEI)

NIH

NCT00081835 - Evaluation and Treatment of Eye Complications of Vaccinia Vaccination | Biotech Hunter | Biotech Hunter